Life sciences and health care companies are navigating the future of manufacturing in an increasingly complex policy and business environment. While automation and digital technologies are transforming manufacturing production systems, companies must also contend with geopolitical tensions, shifting trade policies, and energy constraints as they develop their manufacturing strategies.

Technological transformation

Automation and artificial intelligence (AI) are transforming manufacturing across the sector. Intelligent robotics, digital twins, and AI-driven analytics are enabling real-time production, improving precision and scalability, and optimizing supply chains. These advancements are accelerating growth in areas such as personalized medicine and advanced biologics, creating opportunities for innovation and greater efficiency.

Geopolitical competition and supply chain vulnerability

This transformation is unfolding amid heightened geopolitical uncertainty. China remains a dominant force in global industrial production and controls critical supply chains, including some pharmaceutical ingredients. Recent disruptions – such as China's 2025 restrictions on rare earth exports – underscore the vulnerability of these supply chains. As governments deploy industrial policies and trade measures to manage geopolitical risk, businesses face increasingly complex and unpredictable trade regimes, including tariffs and other policies directly impacting manufacturing. In response, life sciences and health care companies are reassessing supply strategies and manufacturing footprints to manage risks and build resilience.

Energy constraints

Energy availability, cost, and sustainability are emerging as key factors in manufacturing decisions. With electricity grids struggling to meet increasing demand, companies are exploring innovative solutions, including distributed energy resources and small-scale generation and storage systems, to power their manufacturing facilities. These solutions leverage a mix of energy sources – such as solar, nuclear, and natural gas – offering flexibility and facilitating long-term investment planning.

Thriving in the future of manufacturing

The convergence of technological innovation, geopolitical dynamics, and energy constraints is driving a fundamental realignment of cost and risk across global manufacturing systems. Life sciences companies must navigate complex trade-offs – balancing AI investments, tariff volatility, and energy considerations – while positioning for growth. In this era of disruption, agility will be critical. Companies that adapt quickly and strategically to the future of manufacturing will be best positioned to thrive.